Freemasons charities help fund two important projects at the UCL Cancer Institute
Publication date: 8 March 2016
World Cancer Day 2016
Publication date: 4 February 2016
2016 London Marathon team runner - Kevin
Publication date: 1 February 2016
Kevin Smith is part of the 2016 London Marathon team running for the UCL Cancer Institute Research Trust. He said:
“All of us know, or are likely to know, someone who has experienced cancer. For me, a close friend fought serious cancer at UCL - and thankfully, beat it. The team at the UCL Cancer Institute do important, ground-breaking work that will ensure that more types of cancer are treatable and beatable. They helped my friend, and maybe people you know and love too.”
The UCL Cancer Institute houses over 300 scientists with a mission to improve the quality of life and survival for patients with cancer.
To support James and the research taking place at the UCL Cancer Institute please sponsor him
New Ovarian Cancer Drug Approved by NICE
Publication date: 28 January 2016
A new ovarian cancer drug, which has shown to be effective for women with recurrant ovarian cancer in trials carried out by Jonathan Ledermann, Professor of Medical Oncology at the UCL Cancer Institute has been approved for use in the NHS by NICE.
Olaparib (also known as Lynparza) has gained approval for the maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube and peritoneal cancers. The drug will be used by those who have tested positive for BRCA 1 or 2 gene mutations and who have platinum sensitive disease.
The research, published in 2014, showed that women given this drug had a significantly longer progression free survival than those given a placebo (an 82% reduction compared with the watch and wait patients).
Ovarian cancer is the fifth most common cancer in women and those who have BRCA1 or 2 gene mutations have an increased risk of developing the disease.
2016 London Marathon team runner - Luke
Publication date: 27 January 2016
Luke Trickett is running the 2016 Virgin Money London Marathon for a fund organization devoted solely to the discovery of new treatments for cervical cancer. The Debbie Fund, was set up in memory of Debbie Phillips, who died of Cervical Cancer in 2010.
Research into treatments for cervical cancer continues to be very encouraging and work on antibodies developed by the Debbie Fund team has now been published and presented at International conferences. Test tube studies showing that the Debbie Fund antibodies inhibit the migration of cancer cells have been particularly exciting.
Luke said, "Unfortunately in 2105 I have
had a number of close friends and family diagnosed with cancer. Having
previously worked with Debbie's daughter Katy, I understand the importance of the
research into cervical
cancer, and how vital fund raising can be.
I hope by running for the Debbie Fund, I can help to raise the profile and the importance of the great work the researchers at UCL Cancer Institute are doing"
To support Luke's training please sponsor him
2016 London Marathon team runner - James Jaulim
Publication date: 21 January 2016
James Jaulim has joined the 2016 London Marathon team running for the UCL Cancer Institute Research Trust. He said:
“I’m very excited to have the opportunity to run the 2016 London Marathon for the UCL Cancer Institute Research Trust and support the amazing work that the institute does. I’ve seen cancer have a strong and lasting impact on close members of my family and friends, particularly in recent years, and it’s a privilege to be able to do even a small amount to help the vital research that the Institute does.
In addition, the company I work for, NLP Planning, has been a long-term supporter of the Institute. This dates back to assisting UCL with obtaining planning permission for the Cancer Institute building in 2003, and I’m pleased to be able to help continue this link.
I only really took up running in the last year, completing my first marathon in Berlin in September, and I hadn’t anticipated enjoying it as much as I do. I can’t wait to have the opportunity to complete a marathon in my home city on April 24 and to do it for such a good cause!”
To support James please donate here:
2016 London Marathon team runner - Miranda
Publication date: 18 January 2016
Miranda Essex is running the 2016 London Marathon to raise money for the UCL Cancer Institute Research Trust which supports patient centred cancer research at the UCL Cancer Institute.
To sponsor Miranda please click here
2016 London Marathon team runner - Natalie
Publication date: 15 January 2016
Natalie Tanner is running the London Marathon after a member of her family was diagnosed with cancer. She said:
“I have been running since university, mainly for fitness and time to think, I have completed 4 marathons in the last 5 years including the Brighton Marathon and the Beachy Head Marathon.
My aunt was diagnosed with Oesophageal cancer in October 2015, which came as a real shock as she is a fit 60 year old woman. I felt hopeless in the scope of what I could do to help. I decided to run the London Marathon, which I have volunteered at, on a number of occasions with my job as a Podiatrist.
I was and still am inspired by the amount of people running for themselves or for charities. We have all been or may be affected by some form of cancer within our life time, research is the key to help understand and therefore battle this. I am delighted and proud to be running the Virgin London Marathon for the UCL Cancer Institute Research Trust in April 2016.
So please DIG DEEP and SPONSOR ME !!!”
2016 London Marathon team runners - Ed and Laura
Publication date: 14 January 2016
Ed Major and Laura Evans are running the 2016 Virgin Money London Marathon for a fund dedicated to research into a rare cancer, Chordoma.
Chordoma is a rare primary bone cancer (which starts in rather than spreads to bones). It can occur at the base of the skull, the spine or the sacrum and coccyx (base of spine). It is generally slow growing and frequently recurs after treatment.
For those diagnosed with chordoma treatment options are limited. Initial diagnosis is often difficult as its presenting symptoms can mimic more common musculoskeletal pain or other more common diseases.
Professor Flanagan at the UCL Cancer Institute has carried out research which led to a definitive marker for chordoma, but now further work is underway to use these findings to discover how best to treat patients.
All money raised by Ed and Laura will be going towards this research.
Ed said, "After losing my Father to Chordoma in 2015 I am running in his memory. Chordoma UK was closely in his heart as he had hands on experience with what the research could do for all rare cancer sufferers. I hope by running, I can raise the profile of the great work the team at Chordoma UK is doing"
2016 London Marathon team runner - Holly
Publication date: 12 January 2016
Clair lost her mum to breast cancer and her cousin to
ovarian cancer. She was tested for the BRAC1 gene in 2013 and was found to be at a higher risk of familial
breast or ovarian cancer. She eventually had her ovaries removed followed by a bilateral mastectomy in April 2014. During
recovery from these procedures, Clair’s medical team told her they had
found a tumour. She underwent a CT scan and a third operation in the space
of a month to perform a node biopsy. Although the cancer had not spread, she was
advised to have chemotherapy as a precaution.
Clair’s treatment finished in September 2014 and she remains cancer free today. Genetic research was fundamental to Clair’s early diagnosis and the success of her treatment: the lump which was discovered during her mastectomy was too deep to be detected by a physical exam; she is too young to qualify for routine mammograms; and an MRI scan prior to her operation revealed no signs of breast cancer.
November 2014, 3 year old Finn had some small lumps on his scalp. They
grew rapidly over the following weeks. On Christmas Eve his family
received the shattering news that he had Acute Lymphoblastic
Leukaemia. Treatment started immediately. The first seven months were a
near continuous onslaught of drugs, blood draws and dressing changes, over
20 intravenous chemotherapies, 5 blood and 2
platelet transfusions, general anaesthetics and lumbar punctures (he has
had 11 so far), among other things.
is currently in the least intense but longest phase of the treatment
cycle. He’s now able to attend school. He is making new friends and
trying to live as normal a life as possible.
By the time he is 7, he will have had 200 blood tests, over 1,250 doses of chemotherapy,
21 lumbar punctures and been on steroids for the equivalent of 8 months.
To make a donation please visit here
To read Hollys blog please click here
Jeremy Houghton's "Liminal Encounters" charity exhibition
Publication date: 23 September 2015
Internationally acclaimed visual artist Jeremy
Houghton, is showing his support for research at the UCL Cancer
Institute by donating 25% of the sales of purchases to the charity at an
exclusive viewing on Thursday 22nd October
will have the opportunity to see work from his Royal and sporting
residences, alongside his uplifting studies of birds in flight at this
much anticipated London exhibition.
Hosted at Gallery 8, Duke Street
in Central London, visitors will have the opportunity to meet the
artist, who is one of the most collectable British artists of his
generation, with past commissions including HM The Queen and who was
also an official artist for the London 2012 Olympic Games.
you would like to attend this exclusive Private viewing, please email
Helen at h.quirke[at]ucl.ac.uk or call us on
Liminal Encounters will be at Gallery 8 from the 19-23 October.
Please join us and support the UCL Cancer Institute Research Trust.
Promising pre-clinical results for colorectal cancer treatment
Publication date: 24 June 2015
CIRT shortlisted for a £100,000 grant to develop more effective treatments for childhood leukaemia
Publication date: 10 June 2015
Cancer Institute Research Trust has been shortlisted to the final
stages of the Masonic Samaritan Fund Silver Jubilee Research Fund, for a
chance to win a grant of £100,000. Our research is one of five projects
in the running and Freemasons from the Metropolitan Grand Lodge in
London have been asked to nominate their favourite proposal over the
Art Auction in Aid of the UCL Cancer Institute Research Trust
Publication date: 23 April 2015
Local and international contemporary artists have donated original artworks and prints for auction to raise money for one of the UK’s leading Cancer Research Institutes.
The Art Auction will raise funds for University College London (UCL) Cancer Institute to support the dedicated researchers and clinicians who are working towards finding new treatments that will make a real difference to the lives of cancer patients.
This exclusive charity auction, to be held 23rd April at Manette Gallery, in London’s iconic Soho, is a joint partnership venture between UCL Cancer Institute Research Trust and The Groucho Club.
For more information, please contact the team on 020 7679 6325
Running the 2016 London Marathon for the UCL Cancer Institute
Publication date: 23 April 2015
Announcing the First Colin Woolf Memorial Research Award
Publication date: 25 March 2015
Introducing our 2015 Marathon Running Team
Publication date: 28 November 2014
Runners take on the London Marathon
Publication date: 8 May 2013
11 runners took on the 26.2 miles of the London Marathon on 21st April, the warmest weekend of the year after having trained through some of the coldest spring conditions we’ve had in 100 years!
HRH Princess Alexandra celebrates 10 years as Patron
Publication date: 13 March 2013
Winter Newsletter 2014 Celebrating Our Achievements
Publication date: 13 March 2013
Running the 2015 London Marathon
Publication date: 13 March 2013
APPLICATIONS ARE NOW CLOSED
- Have you ever dreamed of running the London Marathon?
- Do you get itchy feet and a nervous tingle when watching the runners pound the streets of London?
- Are you inspired to do something for cancer research that will benefit scientists working at the forefront of cancer research?